Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors

4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors

US Patent 7238706 · Granted Jul 3, 2007

Estimated economic value: $81,678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted tricyclic compounds2025
Modulators of cystic fibrosis transmembrane conductance regulator2025
Modulators of cystic fibrosis transmembrane conductance regulator2025
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2024
Peptide macrocycles against Acinetobacter baumannii2024
Mannose derivatives for treating bacterial infections2023
Peptide macrocycles against Acinetobacter baumannii2021
Libraries of heteroaryl-containing macrocyclic compounds and methods of making a2021
Libraries of heteroaryl-containing macrocyclic compounds and methods of making a2021
2,7-dibromospiro[fluorene-9,4′-piperidine] compounds2021
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2020
Mannose derivatives for treating bacterial infections2020